Colorectal cancer Header
opdivo-dtc-util-nav

Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user fishing with his grandson.
Potential OPDIVO® (nivolumab) user fishing with his grandson.

Your fight against colorectal
cancer (MSI‑H/dMMR)
may
continue here

OPDIVO, alone or with YERVOY, is an FDA-approved immunotherapy option to treat advanced colorectal cancer (MSI-H/dMMR)

Actor portrayals.
OPDIVO or OPDIVO + YERVOY is not approved
for people younger than 12 years of age.

Previously treated colorectal cancer

OPDIVO + YERVOY is a treatment option for certain adults and children 12 years and older who have had prior treatments for MSI-H/dMMR colorectal cancer

Previously treated colorectal cancer

OPDIVO is a treatment option for certain adults and children 12 years and older who have had prior treatments for MSI-H/dMMR colorectal cancer

OPDIVO will not work for everyone. Individual results may vary.

Man exploring real patients stories of experiences with OPDIVO® (nivolumab) or other OPDIVO-based combinations.

Patient stories

Real patients share their experiences with OPDIVO and OPDIVO-based treatments

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about infusions, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO